Home  >  Products  >  PLSCR4 (phospholipid scramblase 4 ) Blocking Peptide (the C terminal of PLSCR4)(100ug)
PLSCR4 (phospholipid scramblase 4 ) Blocking Peptide (the C terminal of PLSCR4)(100ug)

PLSCR4 (phospholipid scramblase 4 ) Blocking Peptide (the C terminal of PLSCR4)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PLSCR4 Antibody (ARP66435_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP66435
Size: 100ug
Weight: 37kDa
Gene: 57088
Format: Lyophilized powder
Target: PLSCR4 may mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. PLSCR4 may play a central role in the initiation of fibrin clot formation, in the activation of mast cells and in the recognition of apoptotic and injured cells by the reticuloendothelial system.
Alternative names: TRA1
See Full Product Listings >